Lawyers at Arnold & Porter and Williams & Connolly on Friday removed an antitrust lawsuit against Bristol-Myers Squibb and Celgene Corp. to California Northern District Court. The suit accuses the defendants of engaging in an anticompetitive scheme to monopolize the market for the cancer treatment drugs Thalomid and Revlimid. The case was filed by Schneider Wallace Cottrell Konecky; and Lowey Dannenberg on behalf of Molina Healthcare, a health care management business offering services through government programs. The case is 3:21-cv-05483, Molina Healthcare, Inc. v. Celgene Corporation et al.